These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 6807339)

  • 1. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
    Wallin R; Martin LF
    J Clin Invest; 1985 Nov; 76(5):1879-84. PubMed ID: 3932474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of vitamin K dependent carboxylation by tetrachloropyridinol and the imidazopyridines.
    Friedman PA; Griep AE
    Biochemistry; 1980 Jul; 19(14):3381-6. PubMed ID: 6773541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K antagonism of coumarin intoxication in the rat.
    Wallin R; Patrick SD; Ballard JO
    Thromb Haemost; 1986 Apr; 55(2):235-9. PubMed ID: 2424118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.
    Wallin R
    Biochem J; 1986 Jun; 236(3):685-93. PubMed ID: 3098238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
    Preusch PC; Suttie JW
    Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
    Fasco MJ; Hildebrandt EF; Suttie JW
    J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of ticrynafen potentiation of coumarin anticoagulant action.
    Preusch PC; Suttie JW
    Biochem Pharmacol; 1983 Aug; 32(16):2393-8. PubMed ID: 6615542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
    Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
    Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K-dependent carboxylation in the developing rat: evidence for a similar mechanism of action of warfarin in fetal and adult livers.
    Wallin R
    Pediatr Res; 1989 Oct; 26(4):370-6. PubMed ID: 2508052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfaquinoxaline inhibition of vitamin K epoxide and quinone reductase.
    Preusch PC; Hazelett SE; Lemasters KK
    Arch Biochem Biophys; 1989 Feb; 269(1):18-24. PubMed ID: 2916837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the vitamin K-dependent carboxylase and vitamin K epoxide reductase in rat liver.
    Suttie JW; Preusch PC
    Haemostasis; 1986; 16(3-4):193-215. PubMed ID: 3530899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA; Suttie JW
    Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
    Thijssen HH; Baars LG; Vervoort-Peters HT
    Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
    Thijssen HH; Drittij-Reijnders MJ
    Br J Haematol; 1993 Aug; 84(4):681-5. PubMed ID: 8217828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
    MacNicoll AD
    Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo.
    Wallin R; Martin LF
    Biochem J; 1987 Jan; 241(2):389-96. PubMed ID: 3593198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by warfarin of liver microsomal vitamin K-reductase in warfarin-resistant and susceptible rats.
    MacNicoll AD; Nadian AK; Townsend MG
    Biochem Pharmacol; 1984 Apr; 33(8):1331-6. PubMed ID: 6712738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.